COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL: CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS

被引：0
|
作者：
Magliano, C. A. [1 ]
Tura, B. R. [1 ]
Santos, M. [1 ]
Senna, K. [1 ]
Costa, M. [1 ]
机构：
[1] Inst Nacl Cardiol, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1066
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY43
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [1] Icatibant in hereditary angioedema: news and challenges
    Bouillet, Laurence
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 267 - 272
  • [2] The effectiveness of Icatibant in the treatment of hereditary angioedema
    Frambach, Y.
    Schumacher, N.
    Grabbe, J.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (10): : 915 - 915
  • [3] Orphan drugs for the treatment of hereditary angioedema
    Farkas, Henriette
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (02): : 141 - 156
  • [4] The icatibant outcome survey: a prospective study of safety and effectiveness of icatibant in a 'real world' setting in patients with hereditary angioedema
    Karon-Klefbom, M.
    [J]. ALLERGY, 2010, 65 : 452 - 452
  • [5] THE COST-EFFECTIVENESS OF ORPHAN DRUGS
    WEINSTEIN, MC
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 (04) : 414 - 415
  • [6] Icatibant effectiveness and utilisation in patients with hereditary angioedema: results from the Czech Republic database
    Krcmova, I
    Skoupa, J.
    Kuklinek, P.
    Zachova, R.
    Hanzlikova, J.
    [J]. ALLERGY, 2013, 68 : 255 - 256
  • [7] Dutch doctors call for EU evaluation of cost effectiveness of high cost orphan drugs
    Sheldon, Tony
    [J]. BRITISH MEDICAL JOURNAL, 2012, 345
  • [8] Assessing the economic challenges posed by orphan drugs
    Drummond, Michael F.
    Wilson, David A.
    Kanavos, Panos
    Ubel, Peter
    Rovira, Joan
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 36 - 42
  • [9] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
    Caballero, Teresa
    Zanichelli, Andrea
    Aberer, Werner
    Maurer, Marcus
    Longhurst, Hilary J.
    Bouillet, Laurence
    Andresen, Irmgard
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [10] Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey
    Maurer, M.
    Longhurst, H. J.
    Bouillet, L.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Aberer, W.
    [J]. ALLERGY, 2020, 75 : 59 - 60
12345